Flecainide inhibits arrhythmogenic Ca²⁺ waves by open state block of ryanodine receptor Ca²⁺ release channels and reduction of Ca²⁺ spark mass
Hilliard, Fredrick A., Steele, Derek S., Laver, Derek, Yang, Zhaokang, Le Marchand, Sylvain J., Chopra, Nagesh, Piston, David W., Huke, Sabine, Knollmann, Björn C.
Inhibition of cardiac Ca²⁺ release channels (RyR2) determines efficacy of class I antiarrhythmic drugs in catecholaminergic polymorphic ventricular tachycardia
Hwang, Hyun Seok, Hasdemir, Can, Laver, Derek, Mehra, Divya, Turhan, Kutsal, Faggioni, Michela, Yin, Huiyong, Knollmann, Björn C.
Mechanisms of cardiac ryanodine receptor inhibition by anti arrhythmic drugs
Mehra, Divya Rajendra
Multiple modes of ryanodine receptor 2 inhibition by flecainide
Mehra, D., Imtiaz, M. S., van Helden, D. F., Knollmann, B. C., Laver, D. R.
RYR2 channel inhibition is the principal mechanism of flecainide action in CPVT
Kryshtal, Dmytro O., Blackwell, Daniel J., Egly, Christian L., Smith, Abigail N., Batiste, Suzanne M., Johnston, Jeffrey N., Laver, Derek R., Knollmann, Bjorn C.
Are you sure you would like to clear your session, including search history and login status?